Exscientia (Recursion) icon

Exscientia (Recursion)

AI drug design company merged with Recursion in 2024. Exscientia pioneered AI-designed small molecules entering clinical trials. Now part of Recursion, contributing chemistry AI and a pipeline of AI-designed drugs.

Visit Website Drug Discovery & Pharma
drug-discovery ai-pharma small-molecule recursion merged

Overview

AI drug design company merged with Recursion in 2024.

Details

Exscientia pioneered AI-designed small molecules entering clinical trials. Now part of Recursion, contributing chemistry AI and a pipeline of AI-designed drugs.

Tags

drug-discovery, ai-pharma, small-molecule, recursion, merged

Back to AI Healthcare Tools